The Relationship Between Bilateral Oophorectomy and Plasma Hormone Levels in Postmenopausal Women

Hormones and Cancer

Volumn 6, Issue 1, 2015, Pages 54-63

  Kotsopoulos, Joanne ^a,b   Shafrir, Amy L ^c,d   Rice, Megan ^c,d   Hankinson, Susan E ^c,d,e   Eliassen, A Heather ^c,d   Tworoger, Shelley S ^c,d   Narod, Steven A ^a,b  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRONE; ESTRONE SULFATE; HORMONE; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; SEX HORMONE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER GROWTH; COMPARATIVE STUDY; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYSTERECTOMY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SURGICAL TECHNIQUE; TESTOSTERONE BLOOD LEVEL; AGED; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GONADAL STEROID HORMONES; HORMONES; HUMANS; MIDDLE AGED; OVARIECTOMY; POSTMENOPAUSE; RISK FACTORS;

EID: 84925461408     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-014-0209-7     Document Type: Article

References (47)

1. Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC (1985) Do regular ovulatory cycles increase breast cancer risk? Cancer 56(5):1206–1208
2. Trichopoulos D, MacMahon B, Cole P (1972) Menopause and breast cancer risk. J Natl Cancer Inst 48(3):605–613
3. Irwin KL, Lee NC, Peterson HB, Rubin GL, Wingo PA, Mandel MG (1988) Hysterectomy, tubal sterilization, and the risk of breast cancer. Am J Epidemiol 127(6):1192–1201
4. Brinton LA, Schairer C, Hoover RN, Fraumeni JF Jr (1988) Menstrual factors and risk of breast cancer. Cancer Invest 6(3):245–254
5. Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton LA (1997) Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 70(2):150–154. doi:10.1002/(SICI)1097-0215(19970117)70:2<150::AID-IJC2>3.0.CO;2-W
6. Parazzini F, Braga C, La Vecchia C, Negri E, Acerboni S, Franceschi S (1997) Hysterectomy, oophorectomy in premenopause, and risk of breast cancer. Obstet Gynecol 90(3):453–456
7. Kreiger N, Sloan M, Cotterchio M, Kirsh V (1999) The risk of breast cancer following reproductive surgery. Eur J Cancer 35(1):97–101
8. Titus-Ernstoff L, Longnecker MP, Newcomb PA, Dain B, Greenberg ER, Mittendorf R, Stampfer M, Willett W (1998) Menstrual factors in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 7(9):783–789
9. Olson JE, Sellers TA, Iturria SJ, Hartmann LC (2004) Bilateral oophorectomy and breast cancer risk reduction among women with a family history. Cancer Detect Prev 28(5):357–360. doi:10.1016/j.cdp.2004.03.003
10. Press DJ, Sullivan-Halley J, Ursin G, Deapen D, McDonald JA, Strom BL, Norman SA, Simon MS, Marchbanks PA, Folger SG, Liff JM, Burkman RT, Malone KE, Weiss LK, Spirtas R, Bernstein L (2011) Breast cancer risk and ovariectomy, hysterectomy, and tubal sterilization in the women’s contraceptive and reproductive experiences study. Am J Epidemiol 173(1):38–47. doi:10.1093/aje/kwq339
11. Gaudet MM, Gapstur SM, Sun J, Teras LR, Campbell PT, Patel AV (2014) Oophorectomy and hysterectomy and cancer incidence in the Cancer Prevention Study-II Nutrition Cohort. Obstet Gynecol 123(6):1247–1255. doi:10.1097/AOG.0000000000000270
12. Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, Alberg AJ, Rollison DE, Dorgan JF, Brinton LA, Overvad K, Kaaks R, Trichopoulou A, Clavel-Chapelon F, Panico S, Duell EJ, Peeters PH, Rinaldi S, Fentiman IS, Dowsett M, Manjer J, Lenner P, Hallmans G, Baglietto L, English DR, Giles GG, Hopper JL, Severi G, Morris HA, Hankinson SE, Tworoger SS, Koenig K, Zeleniuch-Jacquotte A, Arslan AA, Toniolo P, Shore RE, Krogh V, Micheli A, Berrino F, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Lui LY, Cummings SR, Gunter MJ, Rohan TE, Strickler HD (2011) Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer 105(5):709–722. doi:10.1038/bjc.2011.254 bjc2011254
13. Kotsopoulos J, Lubinski J, Lynch HT, Kim-Sing C, Neuhausen S, Demsky R, Foulkes WD, Ghadirian P, Tung N, Ainsworth P, Senter L, Karlan B, Eisen A, Eng C, Weitzel J, Gilchrist DM, Blum JL, Zakalik D, Singer C, Fallen T, Ginsburg O, Huzarski T, Sun P, Narod SA (2012) Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. doi:10.1158/1055-9965.EPI-12-0201
14. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE (1995) Reproducibility of plasma hormone levels in postmenopausal women over a 2–3-year period. Cancer Epidemiol Biomarkers Prev 4(6):649–654
15. Zhang X, Tworoger SS, Eliassen AH, Hankinson SE (2013) Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat 137(3):883–892. doi:10.1007/s10549-012-2391-z
16. Tworoger SS, Eliassen AH, Zhang X, Qian J, Sluss PM, Rosner BA, Hankinson SE (2013) A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. Cancer Res 73(15):4810–4819. doi:10.1158/0008-5472.CAN-13-0665
17. Karlson EW, Chibnik LB, McGrath M, Chang SC, Keenan BT, Costenbader KH, Fraser PA, Tworoger S, Hankinson SE, Lee IM, Buring J, De Vivo I (2009) A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis. Arthritis Res Ther 11(3):R97. doi:10.1186/ar2742
18. Lin JH, Zhang SM, Rexrode KM, Manson JE, Chan AT, Wu K, Tworoger SS, Hankinson SE, Fuchs C, Gaziano JM, Buring JE, Giovannucci E (2013) Association between sex hormones and colorectal cancer risk in men and women. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc 11(4):419. doi:10.1016/j.cgh.2012.11.012
19. Tworoger SS, Lee IM, Buring JE, Hankinson SE (2008) Plasma androgen concentrations and risk of incident ovarian cancer. Am J Epidemiol 167(2):211–218. doi:10.1093/aje/kwm278
20. Jimenez MC, Sun Q, Schurks M, Chiuve S, Hu FB, Manson JE, Rexrode KM (2013) Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women. Stroke. J Cereb Circ 44(7):1784–1789. doi:10.1161/STROKEAHA.111.000485
21. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE (1998) Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90(17):1292–1299
22. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96(24):1856–1865. doi:10.1093/jnci/djh336
23. Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE (2004) Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 64(18):6814–6819. doi:10.1158/0008-5472.CAN-04-1870
24. Hankinson SE, London SJ, Chute CG, Barbieri RL, Jones L, Kaplan LA, Sacks FM, Stampfer MJ (1989) Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem 35(12):2313–2316
25. Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 25(2):165–172
26. Rosner B, Cook N, Portman R, Daniels S, Falkner B (2008) Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol 167(6):653–666. doi:10.1093/aje/kwm348
27. Strauss JF, Barbieri RL (2004) Yen and Jaffe’s reproductive endocrinology: physiology, pathophysiology, and clinical management 5th edn. Elsevier Saunders, Philadelphia
28. Grodin JM, Siiteri PK, MacDonald PC (1973) Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 36(2):207–214. doi:10.1210/jcem-36-2-207
29. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591. doi:10.1038/nrc1408 nrc1408
30. Riedel HH, Lehmann-Willenbrock E, Semm K (1986) Ovarian failure phenomena after hysterectomy. J Reprod Med 31(7):597–600
31. Pete I, Bosze P (1998) The fate of the retained ovaries following radical hysterectomy. Eur J Gynaecol Oncol 19(1):22–24
32. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Mühlen D (2000) Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 85(2):645–651. doi:10.1210/jcem.85.2.6405
33. Burger HG (1996) The endocrinology of the menopause. Maturitas 23(2):129–136
34. Kaaks R, Tikk K, Sookthai D, Schock H, Johnson T, Tjonneland A, Olsen A, Overvad K, Clavel-Chapelon F, Dossus L, Baglietto L, Rinaldi S, Chajes V, Romieu I, Boeing H, Schutze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Tumino R, Ricceri F, Mattiello A, Buckland G, Ramon Quiros J, Sanchez MJ, Amiano P, Chirlaque MD, Barricarte A, Bas Bueno-de-Mesquita H, van Gils CH, Peeters PH, Andersson A, Sund M, Weiderpass E, Khaw KT, Wareham N, Key TJ, Travis RC, Merritt MA, Gunter MJ, Riboli E, Lukanova A (2013) Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status—results from the EPIC cohort. Int J Cancer J Int du Cancer. doi:10.1002/ijc.28528
35. Key TJ, Appleby PN, Reeves GK, Travis RC, Alberg AJ, Barricarte A, Berrino F, Krogh V, Sieri S, Brinton LA, Dorgan JF, Dossus L, Dowsett M, Eliassen AH, Fortner RT, Hankinson SE, Helzlsouer KJ, Hoff Man-Bolton J, Comstock GW, Kaaks R, Kahle LL, Muti P, Overvad K, Peeters PH, Riboli E, Rinaldi S, Rollison DE, Stanczyk FZ, Trichopoulos D, Tworoger SS, Vineis P (2013) Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 14(10):1009–1019. doi:10.1016/S1470-2045(13)70301-2
36. Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8):606–616
37. Eliassen AH, Hankinson SE (2008) Endogenous hormone levels and risk of breast, endometrial and ovarian cancer: prospective studies. In: Berstein RJ (ed) Innovative endocrinology of cancer. Landes Bioscience, New York, pp 148–165
38. Liao DJ, Dickson RB (2002) Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J Steroid Biochem Mol Biol 80(2):175–189
39. Tworoger SS, Zhang X, Eliassen AH, Qian J, Colditz GA, Willett WC, Rosner BA, Kraft P, Hankinson SE (2014) Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer. J Clin Oncol 32(28):3111–3117. doi:10.1200/JCO.2014.56.1068
40. Crave JC, Lejeune H, Brebant C, Baret C, Pugeat M (1995) Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells. J Clin Endocrinol Metab 80(4):1283–1289. doi:10.1210/jcem.80.4.7536204
41. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, Hallmans G, Stattin P, Toniolo P, Kaaks R (2004) Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol / Eur Fed Endoc Soc 150(2):161–171
42. Longcope C (1986) Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab 15(2):213–228
43. Nichols HB, Visvanathan K, Newcomb PA, Hampton JM, Egan KM, Titus-Ernstoff L, Trentham-Dietz A (2011) Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery? Am J Epidemiol 173(10):1111–1120. doi:10.1093/aje/kwq510
44. Woolcott CG, Maskarinec G, Pike MC, Henderson BE, Wilkens LR, Kolonel LN (2009) Breast cancer risk and hysterectomy status: the Multiethnic Cohort study. Cancer Causes Control 20(5):539–547. doi:10.1007/s10552-008-9262-2
45. Danforth KN, Eliassen AH, Tworoger SS, Missmer SA, Barbieri RL, Rosner BA, Colditz GA, Hankinson SE (2010) The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women. Int J Cancer 126(1):199–207. doi:10.1002/ijc.24709
46. Diaz-Cruz ES, Sugimoto Y, Gallicano GI, Brueggemeier RW, Furth PA (2011) Comparison of increased aromatase versus ER {alpha} in the generation of mammary hyperplasia and cancer. Cancer Res 71(16):5477–5487. doi:10.1158/0008-5472.CAN-10-4652
47. Nichols HB, Visvanathan K, Newcomb PA, Hampton JM, Egan KM, Titus-Ernstoff L, Trentham-Dietz A (2011) Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery? Am J Epidemiol 173(10):1111–1120. doi:10.1093/aje/kwq510